Simcere Pharmaceutical Group
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A major Chinese pharma company developing and commercializing innovative and generic drugs in key therapeutic areas.
OncologyCardiovascularInfectious Disease
Technology Platform
Engages in small molecule and biologic drug discovery, with a growing focus on antibody-drug conjugate (ADC) technology platforms.
Funding History
1Public OfferingUndisclosed
Opportunities
Benefiting from China's healthcare reform and insurance coverage expansion for innovative medicines.
Risk Factors
Faces pricing pressure from national volume-based procurement policies and pipeline execution risks for novel assets.
Competitive Landscape
Competes in the crowded Chinese pharmaceutical market against other large integrated players, with competition intensifying in innovative drug segments.